Our study has expanded our understanding of the complex regulatory mechanism of interaction and the role of EGFR/MAP2K1/MTOR/YAP1 within the TME of NSCLC and suggests the translational immunotherapeutic potential of NLOC-015A. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.